PRMT5 and adrenal cortex carcinoma: Experiments carried out in two organoid models also resulted in substantially decreased viability and downregulation of MYB and MYC mRNA expression (Fig. 5E and F), further supporting the role of PRMT5 in regulating the tumorigenic potential of ACC cells in vitro.